Skip to content
Open access

Prognostic significance of the TMPO-AS1/ hsa-let-7b-5p axis and nTreg infiltration in lung adenocarcinoma: an in silico analysis

Aug 2026 · BMC Pulmonary Medicine · 0 citations

TL;DR

A robust G2/M -associated regulatory framework in LUAD is defined, characterized by reciprocal dysregulation of oncogenes and tumor suppressors and associated with the predicted TMPO-AS1–hsa-let-7b-5p regulatory network, which is linked to a less immunosuppressive tumor microenvironment, offering potential prognostic and therapeutic implications in LUAD.

Abstract

While several G2/M oncogenes are known to promote tumor progression, their coordinated tumor-suppressive networks antagonizing this axis and their regulatory and immunological contexts remain poorly defined. We performed a multi-layered integrative analysis combining correlation profiling (UALCAN and ENCORI), multi-endpoint survival analysis (KM Plotter: OS, FPS, PPS across pan-lung, LUAD, and smoker cohorts), and transcriptomic refinement using TNMplot. A miRNA–mRNA regulatory network was constructed via miRNet, refined using UALCAN expression filtering, KM survival, and CancerMIRNome ROC analysis, followed by ENCORI-based miRNA–gene correlation. Direct miRNA–mRNA and lncRNA–miRNA binding affinities were assessed using IntaRNA. lncRNAs associated with the key miRNA were identified via Enrichr, filtered by expression, correlation, and survival, and validated by binding and gene correlation analyses. Finally, immune cell correlations were evaluated using GSCA, and an integrated ROC model was generated in R. We identified a high-confidence panel of six tumor suppressors (CBX7, CD81, CRY2, CYBRD1, NR3C2, REEP5) and six G2/M oncogenes (AURKA, AURKB, BUB1, FOXM1, MELK, TTK) based on correlation, survival, and TNMplot criteria. hsa-let-7b-5p emerged as a central regulatory miRNA (AUC = 0.89) positively correlated with tumor suppressors and predicted to bind all six oncogenes. TMPO-AS1 was identified as an oncogenic lncRNA antagonizing hsa-let-7b-5p via strong binding (–15.85 kcal/mol) and negative correlation with tumor suppressors. An integrated lncRNA-miRNA-mRNA ROC model achieved an AUC ≈ 0.97. Immune analysis revealed reciprocal patterns: tumor suppressors correlated with MAIT, NKT, and Tfh cells and inversely with exhausted cells and nTregs, whereas oncogenes showed the opposite trend with the same. This study defines a robust G2/M -associated regulatory framework in LUAD, characterized by reciprocal dysregulation of oncogenes and tumor suppressors and associated with the predicted TMPO-AS1–hsa-let-7b-5p regulatory network, which is linked to a less immunosuppressive tumor microenvironment, offering potential prognostic and therapeutic implications in LUAD.

Read PDF

Similar papers

Open access Aug 2026

Prognostic significance of the MELK/TMPO-AS1/hsa-let-7b-5p network in lung adenocarcinoma

Introduction Maternal Embryonic Leucine Zipper Kinase (MELK) is a key regulator of the G2/M checkpoint and a recognized pan-cancer oncogene; however, its regulatory mechanisms and clinical significance in lung adenocarcinoma (LUAD) remain incompletely understood. This study aimed to investigate the molecular, prognosti...

Kritika Jangir, Niranjan Kumar, Chainsee Saini et al. · 0 citations
Open access Jan 2026

Integrative Pan‐Cancer Characterization of lncRNA UPK1A‐AS1 and Its Role in Hypoxia‐Associated Sorafenib Resistance in Hepatocellular Carcinoma

It is suggested that UPK1A-AS1 is a hypoxia‐inducible oncogenic lncRNA that plays dual roles in cancer, with cancer type‐dependent associations with progression and immune modulation across malignancies and mechanistically mediating hypoxia‐associated drug resistance in HCC.

Ze-Kai Li, Min Luo, Shu-Sen Fang et al. · 0 citations
Open access Aug 2026

tRF-28-ZJ47D112Z4DZ suppresses gastric cancer progression via Ago2-mediated regulation of the CCND1-associated cell cycle pathway and serves as a complementary plasma biomarker.

INTRODUCTION Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, highlighting the need for improved non-invasive biomarkers for early detection and prognostic evaluation. tRNA-derived fragments (tRFs) have emerged as regulatory non-coding RNAs in cancer, but their biological and clinical...

Xiuchong Yu, Jia-Ning Tong, Yaoyao Xie et al. · 0 citations
Open access Sep 2026

Inflammation-associated hsa_circ_0054391 regulates epithelial-mesenchymal transition and vasculogenic mimicry in colorectal cancer via the miR-1252-3p/VEGFA/ZEB1 axis

To define the functional role of hsa_circ_0054391 (circ54391) in CRC progression and to evaluate its potential as a serum biomarker. Circ54391 was identified from databases and its expression was validated in CRC tissues, cell lines, and serum from healthy controls ( n  = 34), colorectal polyp patients ( n  = 3...

Cheng-Ying Xiong, Zhi-Qiang He, Xiao-Xue Liu et al. · 0 citations
Open access Aug 2026

Exploratory Multi-Platform Bioinformatic Analysis of MEAK7 and Its Molecular, Survival, and Immune Associations in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is associated with high mortality owing to late diagnosis, aggressive tumor biology, and limited clinically useful early diagnostic and prognostic biomarkers. This study provides an exploratory evaluation of the expression profile, survival associations, co-expressed genes, funct...

Meltem Uyaner Kan, D. Ayan · 0 citations
Open access Sep 2026

LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis

LncRNAs are crucial regulators and biomarkers in various cancers. However, their expression and functions in esophageal squamous cell carcinoma (ESCC) remain largely unexplored. This study explored the clinial relevance and mechanisms of LncRNA DLGAP1-AS2 in ESCC. Utilizing the GEO dataset, the identification of differ...

Li-Wei Tang, Yi-Chuan Zhang, Xiang-Ting Cheng · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.